Validation of the pharmacokinetic model for anti- TNFα clearance in infants exposed to anti- TNFα during pregnancy.

Jantien W WieringaMatthijs D KruizingaGertjan J A DriessenC Janneke van der WoudeMette Julsgaard

Published in: Journal of Crohn's & colitis (2023)

The validity of the anti-TNFα clearance model is high, and hence can be used to guide clinicians regarding timing of live vaccines in infants exposed to adalimumab or infliximab in utero.

Keyphrases

rheumatoid arthritis
ulcerative colitis